- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04237480
Influence of Kidney Performance and Magnesium on Formation of (OH)2-vitamin D3
February 10, 2020 updated by: University Hospital, Basel, Switzerland
Influence of Kidney Performance and Magnesium on the Biomarkers of Vitamin D
Retrospective database analysis.
The target values are the serum values of 25(OH)D, of 1,25(OH)2D, of magnesium and creatinine as well as age and sex of the patients.
The laboratory values of the years 2017 and 2018 are included.
There are no additional measurements on patients.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The laboratory values of the years 2017 and 2018 are included.
All laboratory results to be evaluated originate from Medics Labor in Bern.
We expect about 50'000 data sets.
It is impossible for the study team to draw conclusions about the patients or the senders.
Study Type
Observational
Enrollment (Actual)
50000
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
no restriction
Description
Inclusion Criteria:
- all data sets available
Exclusion Criteria:
- a declaration from the patient that his laboratory values may not be included in an evaluation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
correlation of serum values of 1,25(OH)2 vitamin D with estimated glomerular filtration rate
Time Frame: 2017 - 2018
|
statistical evaluation of serum values
|
2017 - 2018
|
correlation of serum values of 1,25(OH)2 vitamin D with magnesium
Time Frame: 2017 - 2018
|
statistical evaluation of serum values
|
2017 - 2018
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2017
Primary Completion (Actual)
December 31, 2018
Study Completion (Actual)
May 28, 2019
Study Registration Dates
First Submitted
January 17, 2020
First Submitted That Met QC Criteria
January 22, 2020
First Posted (Actual)
January 23, 2020
Study Record Updates
Last Update Posted (Actual)
February 11, 2020
Last Update Submitted That Met QC Criteria
February 10, 2020
Last Verified
February 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018-00923
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hydroxylase Deficiency
-
Mayo ClinicRecruiting24-hydroxylase DeficiencyUnited States
-
Vanderbilt UniversityApproved for marketing
-
Vanderbilt University Medical CenterCompletedAutonomic Nervous System Diseases | Orthostatic Hypotension | Orthostatic Intolerance | Dopamine Beta-Hydroxylase DeficiencyUnited States
-
Vanderbilt UniversityNational Heart, Lung, and Blood Institute (NHLBI)TerminatedAutonomic Nervous System Diseases | Orthostatic Hypotension | Orthostatic Intolerance | Dopamine Beta-Hydroxylase DeficiencyUnited States
-
Assistance Publique - Hôpitaux de ParisUnknown
-
Orphanetics Pharma Entwicklungs GmbHTerminatedPhenylalanine Hydroxylase Deficiencies
-
Maria I. NewNational Center for Research Resources (NCRR); Office of Rare Diseases (ORD)Completed21-hydroxylase DeficiencyUnited States, Brazil
-
Johnson & Johnson Pharmaceutical Research & Development...Completed21-hydroxylase DeficiencyUnited States
-
Assistance Publique - Hôpitaux de ParisUnknownAdrenal Hyperplasia, Congenital | 21-hydroxylase DeficiencyFrance
-
Chelsea TherapeuticsCompletedNeurogenic Orthostatic Hypotension | Primary Autonomic Failure | Dopamine Beta Hydroxylase Deficiency | Non-Diabetic Neuropathy
Clinical Trials on serum value 1,25(OH)2 vitamin D
-
National Institute on Aging (NIA)CompletedCognitive Impairment | Cognitive DeclineUnited States
-
Wenhu LiuBeijing Municipal Science & Technology CommissionUnknownVitamin D Deficiency | MalnutritionChina
-
Dongliang Zhang, MDBeijing Municipal Science & Technology CommissionCompletedVitamin D DeficiencyChina
-
University Hospitals Cleveland Medical CenterEmory UniversityCompleted
-
University Hospital, CaenUnknown
-
University Hospital, Clermont-FerrandCentre de Recherche en Nutrition Humaine Rhone-Alpe; Centre de Recherche en... and other collaboratorsUnknown
-
Clalit Health ServicesCompletedVitamin D Deficiency | Secondary Hyperparathyroidism | OsteomalaciaIsrael
-
University of MinnesotaCompletedVitamin D DeficiencyUnited States
-
University of AlexandriaCompletedSystemic Lupus ErythematosusEgypt
-
Hospices Civils de LyonCompletedVitamin D Deficiency | Sickle Cell DiseaseFrance